Invesaro

Stocks IMCR Earnings

Earnings

Immunocore Holdings plc (IMCR) earnings

Quarterly results of Immunocore Holdings plc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when IMCR files with the SEC.

Next earnings date

Immunocore Holdings plc is expected to report around January 8, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Immunocore Holdings plc reported revenue of $102.2M (-1.4% on the same quarter a year earlier) and a net loss of $14.2M.

Diluted earnings per share were -$0.28.

Filed with the SEC on November 6, 2026.

Revenue by quarter
Q4 24: $84.1M $84.1M Q4 24Q1 25: $93.9M $93.9M Q1 25Q2 25: $98M $98M Q2 25Q3 25: $103.7M $103.7M Q3 25Q4 25: $104.5M $104.5M Q4 25Q1 26: $106.7M $106.7M Q1 26Q2 26: $115.9M $115.9M Q2 26Q3 26: $102.2M $102.2M Q3 26
Net income by quarter
Q4 24: -$23.8M -$23.8M Q4 24Q1 25: $5M $5M Q1 25Q2 25: -$10.3M -$10.3M Q2 25Q3 25: -$177K -$177K Q3 25Q4 25: -$30.1M -$30.1M Q4 25Q1 26: $13M $13M Q1 26Q2 26: -$808K -$808K Q2 26Q3 26: -$14.2M -$14.2M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$102.2M-1.4%-$14.2M-$0.28
Q2 FY2026June 30, 2026$115.9M+18.3%-$808K-$0.02
Q1 FY2026March 31, 2026$106.7M+13.6%$13M$0.25
Q4 FY2025December 31, 2025$104.5M+24.3%-$30.1M-
Q3 FY2025September 30, 2025$103.7M--$177K$0.00
Q2 FY2025June 30, 2025$98M--$10.3M-$0.20
Q1 FY2025March 31, 2025$93.9M-$5M$0.10
Q4 FY2024December 31, 2024$84.1M--$23.8M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Immunocore Holdings plc's next earnings date?

Immunocore Holdings plc is expected to report around January 8, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Immunocore Holdings plc's latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Immunocore Holdings plc reported revenue of $102.2M and a net loss of $14.2M. The figures come from its filing with the SEC.

Is Immunocore Holdings plc's revenue growing?

Revenue in Q3 FY2026 was $102.2M, down 1.4% from $103.7M in the same quarter a year earlier.

Get an email when IMCR reports

Follow IMCR and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when IMCR files with the SEC.

Source: quarterly figures Immunocore Holdings plc tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Immunocore Holdings plc